MARJORIE REEVES: Open Payments
NPI 1851548952 · CRESTVIEW HILLS, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$826 in 45 payments from 13 companies in 2025. Trend: 2023 $1,246 · 2024 $771 · 2025 $826
Food & beverage: $826
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 13 | $249 |
| ABBVIE INC. | 4 | $106 |
| Corium, LLC | 6 | $69 |
| Neurocrine BioSciences, Inc. | 4 | $68 |
| Axsome Therapeutics, Inc. | 3 | $66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $63 |
| Tris Pharma Inc | 3 | $48 |
| Lundbeck LLC | 2 | $41 |
| Collegium Pharmaceutical, Inc. | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 2 | $28 |
Products named: Qelbree, VRAYLAR, Azstarys, INGREZZA, Auvelity, CAPLYTA, REXULTI, Dyanavel XR.
Industry payments across KY — which companies pay providers there.
